When Genae Girard was diagnosed with breast cancer at 36, her doctors recommended she get tested for two genes that relate to an elevated risk of breast and ovarian cancer - BRCA1 and BRCA2. That's when Genae found out only one company could test for the mutation: Myriad Genetics. Myriad holds the patent on those two genes, along with the gene test. After she tested positive, Genae had to make the difficult decision about having her breasts and healthy ovaries removed, without a second opinion.
Genae and other women have now signed on to a federal lawsuit to get these patents reversed. They say no company has the right to have a patent over human genes.